You are using an outdated browser. Please upgrade your browser to improve your experience.

eculizumab

Ligand Summary
Description
a recombinant humanized monoclonal IgG2/4k antibody produced by murine myeloma cell culture, specifically binds to the complement protein C5 with high affinity, thereby inhibiting its cleavage to C5a and C5b and preventing the generation of the terminal complement complex C5b-9
Synonyms & Links
DrugCentral: 4969
LyCHI:  eculizumab


loading...
Target Activities